Yoruba religion

DGAP-News: ADM Energy PLC: Change of Broker

Retrieved on: 
Thursday, November 12, 2020
Iyami Aje, Yoruba religion, Albian, Petroleum reservoir, Geology

ADM Energy PLC (AIM: ADME; BER and FSE: P4JC) is a natural resources investing company with an existing asset base in Nigeria.

Key Points: 
  • ADM Energy PLC (AIM: ADME; BER and FSE: P4JC) is a natural resources investing company with an existing asset base in Nigeria.
  • ADM Energy holds a 5% profit interest in the Aje Field, part of OML 113, which covers an area of 835km offshore Nigeria, and in February 2020 entered into an agreement with EER (Colobos) Nigeria Limited to acquire a further 4.2% profit interest.
  • Aje has multiple oil, gas, and gas condensate reservoirs in the Turonian, Cenomanian and Albian sandstones with five wells drilled to date.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Innovation For Equity Announces Winners for 2020 IFE Awards

Retrieved on: 
Wednesday, August 5, 2020
Yoruba, IFE, Yoruba religion, Geography of Nigeria, Traditional African religions

BOSTON, Aug. 5, 2020 /PRNewswire/ -- Innovation For Equity, Inc. (IFE), a nonprofit organization committed to promoting innovative ways to improve life outcomes for Black learners of all ages, today announced the winners of its 2020 IFE Awards.

Key Points: 
  • BOSTON, Aug. 5, 2020 /PRNewswire/ -- Innovation For Equity, Inc. (IFE), a nonprofit organization committed to promoting innovative ways to improve life outcomes for Black learners of all ages, today announced the winners of its 2020 IFE Awards.
  • Presented annually, the IFE Awards honor leaders who are working to disrupt educational inequities and create greater opportunities for Black learners cradle through career.
  • The IFE Awards represents the culmination of this year's IFE free Summer Virtual Events series.
  • This year's IFE Awards Ceremony and Reception will be a highly interactive virtual event on Thursday, August 6 at 4:00pm ET.

Ori Biotech Announces a $9.4M Seed Round to Advance Innovation in Cell and Gene Therapy Manufacturing

Retrieved on: 
Thursday, January 9, 2020
Ori, Yoruba culture, Yoruba religion, General Confederation of Labour, Trade unions, Culture, Organizations

LONDON and PHILADELPHIA, Jan. 9, 2020 /PRNewswire/ --Ori Biotech Ltd (Ori), an innovator in Cell and Gene Therapy (CGT) manufacturing,today announced that they successfully closed a $9.4M (7M) seed round which will be used to bring their innovative manufacturing platform to market.

Key Points: 
  • LONDON and PHILADELPHIA, Jan. 9, 2020 /PRNewswire/ --Ori Biotech Ltd (Ori), an innovator in Cell and Gene Therapy (CGT) manufacturing,today announced that they successfully closed a $9.4M (7M) seed round which will be used to bring their innovative manufacturing platform to market.
  • The Ori platform will deliver scalable solutions to flexibly address the critical clinical and commercial manufacturing needs of CGT developers.
  • Jason C. Foster, newly appointed CEO of Ori Biotech said:"The successful financing underscores the potential of the Ori platform to fully automate cell and gene therapy manufacturing to increase throughput, improve quality and decrease costs.
  • Ori Biotech at JP Morgan Healthcare Conference, San Francisco
    The Ori Biotech team will be at the 38th Annual J.P. Morgan Healthcare Conference on 13-16 January 2020 in San Francisco, California.

Ori Biotech Announces a $9.4M Seed Round to Advance Innovation in Cell and Gene Therapy Manufacturing

Retrieved on: 
Thursday, January 9, 2020
Financial services, Finance, Banking, Ori, Yoruba culture, Yoruba religion, JPMorgan Chase, General Confederation of Labour

The Ori platform will deliver scalable solutions to flexibly address the critical clinical and commercial manufacturing needs of CGT developers.

Key Points: 
  • The Ori platform will deliver scalable solutions to flexibly address the critical clinical and commercial manufacturing needs of CGT developers.
  • Jason C. Foster, newly appointed CEO of Ori Biotech said:"The successful financing underscores the potential of the Ori platform to fully automate cell and gene therapy manufacturing to increase throughput, improve quality and decrease costs.
  • We look forward to collaborating with best-in-class suppliers, service providers and therapeutics developers to create next generation manufacturing solutions.
  • Ori Biotech at JP Morgan Healthcare Conference, San Francisco
    The Ori Biotech team will be at the 38th Annual J.P. Morgan Healthcare Conference on 13-16 January 2020 in San Francisco, California.